Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.4K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.8K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

22.7K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
22.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.5K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phylogenetic Analysis and In Vitro Antimicrobial Potential of Some Herbal Extracts Against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Isolate Recovered From Hospital Wastes.

Journal of tropical medicine·2026
Same author

Bioactive Chitin-Based Thermosensitive Hydrogel Reinforces Stem Cell Therapy for Osteoarthritis.

Biomaterials research·2026
Same author

Effects of Heat-Moisture Treatment on the Physicochemical Properties, Structural Characteristics, and Anti-Ulcerative Colitis Activity of Yam Starch.

Journal of agricultural and food chemistry·2026
Same author

Alzheimer's disease and apitherapy: the therapeutic effect of various honeybee products.

Neurodegenerative disease management·2026
Same author

Phytochemical profiling, green synthesis of Ag, Cu, Fe, and Zn nanoparticles, and in vitro biological activities of Delphinium brunonianum Royle.

Scientific reports·2026
Same author

Divergent physiological and biochemical strategies confer differential salinity and drought tolerance in five prevalent summer weeds.

Biologia futura·2026

Related Experiment Video

Updated: Nov 15, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.2K

Boswellic acids: privileged structures to develop lead compounds for anticancer drug discovery.

Hidayat Hussain1, Iftikhar Ali2,3, Daijie Wang2

  • 1Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg, Germany.

Expert Opinion on Drug Discovery
|March 2, 2021
PubMed
Summary

Boswellic acids (BAs) and their derivatives show potent anticancer effects. Future research on specific semisynthetic BAs, like ring A cyanoenones, could lead to novel cancer treatments.

Keywords:
Boswellic acidsanticancerbas derivativesfrankincensein vitroin vivo

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.8K
Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

900

Related Experiment Videos

Last Updated: Nov 15, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.2K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.8K
Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

900

Area of Science:

  • Natural product chemistry
  • Medicinal chemistry
  • Oncology

Background:

  • Cancer is a leading global cause of death, necessitating novel therapeutic strategies.
  • Natural boswellic acids (BAs) from frankincense exhibit promising in vitro and in vivo anticancer activities.
  • Semisynthetic derivatives of BAs are being explored for enhanced therapeutic potential.

Purpose of the Study:

  • To review the significance of boswellic acids (BAs) in developing future cancer treatments.
  • To describe potent semisynthetic BA derivatives and their mechanisms of action.
  • To identify key structural features of semisynthetic BAs responsible for cytotoxic effects.

Main Methods:

  • Comprehensive literature review of boswellic acids and their derivatives.
  • Analysis of structure-activity relationships for cytotoxic effects.
  • Exploration of synergistic potential with other anticancer agents.

Main Results:

  • Numerous semisynthetic BAs demonstrate significant cytotoxic effects against cancer cells.
  • Derivatives with ring A cyanoenone moieties, endoperoxides, and hybrid structures exhibit superior potency.
  • Boswellic acids can be conjugated with other anticancer compounds for synergistic effects.

Conclusions:

  • Semisynthetic boswellic acids, particularly those with specific structural modifications, hold great promise for cancer therapy.
  • Further research into ring A cyanoenones, endoperoxides, and C-24 amide analogs is crucial for developing lead anticancer compounds.
  • The potential for synergistic combinations highlights the versatility of BAs in cancer treatment strategies.